menarini-group-receives-positive-chmp-opinion-recommending-ec-approval-of-orserdu-(elacestrant)-for-the-treatment-of-patients-with-er+,-her2-locally-advanced-or-metastatic-breast-cancer-with-an-activating-esr1-mutation